Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Journal of Neurosurgery|October 15, 2013
Improvement in clinical outcomes following optimal targeting of brain ventricular catheters with intraoperative imagingChristopher G Janson, Liudmila G Romanova, Kyle D Rudser, et al.Pediatric Neurology|October 1, 2005
Lithium citrate for Canavan diseaseChristopher G Janson, Mitra Assadi, Jeremy Francis, et al.Journal of the Neurological Sciences|May 22, 2007
Treatment of spinocerebellar ataxia with buspironeMitra Assadi, Joseph V Campellone, Christopher G Janson, et al.Journal of the Neurological Sciences|January 15, 2008
Validating an Ataxia Functional Composite Scale in spinocerebellar ataxiaMitra Assadi, Paola Leone, J Jon Veloski, et al.Nature Medicine|September 16, 2025
Oligodendrocyte-targeted adeno-associated virus gene therapy for Canavan disease in children: a phase 1/2 trialPaola Leone, Robert M Lober, Jeremy Francis, et al.Neurosurgery|October 1, 2013
Comparison of Endovascular and Intraventricular Gene Therapy With Adeno-Associated Virus-α-L-Iduronidase for Hurler DiseaseChristopher G Janson, Liudmila G Romanova, Paola Leone, et al.Clinical Biochemistry|September 6, 2005
Simultaneous high performance liquid chromatographic separation of purines, pyrimidines, N-acetylated amino acids, and dicarboxylic acids for the chemical diagnosis of inborn errors of metabolismBarbara Tavazzi, Giuseppe Lazzarino, Paola Leone, et al.Neurobiology of Disease|October 9, 2016
N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylaseJeremy S Francis, Ireneusz Wojtas, Vladimir Markov, et al.Annals of Neurology|January 27, 2006
Mild-onset presentation of Canavan's disease associated with novel G212A point mutation in aspartoacylase geneChristopher G Janson, Edwin H Kolodny, Bai-Jin Zeng, et al.Science Translational Medicine|December 21, 2012
Long-term follow-up after gene therapy for canavan diseasePaola Leone, David Shera, Scott W J McPhee, et al.Pageof 1